Dinarello CA - Search Results

1

Circulating interleukin-1 and tumor necrosis factor antagonists in liver disease.

Tilg H, Vogel W, Wiedermann CJ, Shapiro L, Herold M, Judmaier G, Dinarello CA. Tilg H, et al. Among authors: dinarello ca. Hepatology. 1993 Nov;18(5):1132-8. Hepatology. 1993. PMID: 8225219

2

Interferon-alpha induces circulating tumor necrosis factor receptor p55 in humans.

Tilg H, Vogel W, Dinarello CA. Tilg H, et al. Among authors: dinarello ca. Blood. 1995 Jan 15;85(2):433-5. Blood. 1995. PMID: 7811997 Free article.

3

Induction of circulating soluble tumour necrosis factor receptor and interleukin 1 receptor antagonist following interleukin 1 alpha infusion in humans.

Tilg H, Trehu E, Shapiro L, Pape D, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. Cytokine. 1994 Mar;6(2):215-9. doi: 10.1016/1043-4666(94)90044-2. Cytokine. 1994. PMID: 8032003 Clinical Trial.

4

Induction of circulating antagonists to IL-1 and TNF by IL-2 administration and their effects on IL-2 induced cytokine production in vitro.

Tilg H, Shapiro L, Vannier E, Poutsiaka DD, Trehu E, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. J Immunol. 1994 Mar 15;152(6):3189-98. J Immunol. 1994. PMID: 8144913

5

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55.

Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. Blood. 1994 Jan 1;83(1):113-8. Blood. 1994. PMID: 8274730 Free article. Clinical Trial.

6

Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera.

Tilg H, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. J Immunol. 1993 Sep 15;151(6):3299-307. J Immunol. 1993. PMID: 8397255

7

Induction of circulating IL-1 receptor antagonist by IFN treatment.

Tilg H, Mier JW, Vogel W, Aulitzky WE, Wiedermann CJ, Vannier E, Huber C, Dinarello CA. Tilg H, et al. Among authors: dinarello ca. J Immunol. 1993 May 15;150(10):4687-92. J Immunol. 1993. PMID: 8482853 Clinical Trial.

8

Antiinflammatory properties of hepatic acute phase proteins: preferential induction of interleukin 1 (IL-1) receptor antagonist over IL-1 beta synthesis by human peripheral blood mononuclear cells.

Tilg H, Vannier E, Vachino G, Dinarello CA, Mier JW. Tilg H, et al. Among authors: dinarello ca. J Exp Med. 1993 Nov 1;178(5):1629-36. doi: 10.1084/jem.178.5.1629. J Exp Med. 1993. PMID: 7693853 Free PMC article.

9

A randomized, controlled trial of IL-10 in humans. Inhibition of inflammatory cytokine production and immune responses.

Chernoff AE, Granowitz EV, Shapiro L, Vannier E, Lonnemann G, Angel JB, Kennedy JS, Rabson AR, Wolff SM, Dinarello CA. Chernoff AE, et al. Among authors: dinarello ca. J Immunol. 1995 May 15;154(10):5492-9. J Immunol. 1995. PMID: 7730651 Clinical Trial.

10

Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts.

Lonnemann G, Shapiro L, Engler-Blum G, Müller GA, Koch KM, Dinarello CA. Lonnemann G, et al. Among authors: dinarello ca. Kidney Int. 1995 Mar;47(3):837-44. doi: 10.1038/ki.1995.126. Kidney Int. 1995. PMID: 7752582 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,093 results

Search Page

Filters